-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Step I Mult. Myeloma
Started by Cristagali
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
Methinks that a monoclonal and pathologic IgG- or IgA-producing line of lympocytes will be VERY high (the M protein!), but overall, normal IgG that can protect against infection will be low. The normal lymphocytes (and other marrow components) will be crowded out by the pathologic monoclonal line. But please, don't take my word for it.
yeah, I think you are right. yes, there is an increase in the monoclonal patho IgG, but still a decreased function, hence, increased risk to certain infections, (implied that normal IgG is decreased and overwhelmed) Thanks for the input. 😎
agree w/ above. monoclonal expansion of a single plasma cell line will produce IgG with singular antigen specificity. It will also depress normal production of IgM, IgG, IgA etc, therefore reducing the humoral immune response to new antigenic challenge.
Advertisement - Members don't see this ad
Actually, you could have really 😉 kick-ass humoral response to that one antigen
The other thing to think of too is that most of the time the antibody produced in MM is just the light chain fragment and not necessarily the entire, complete IgG. However, when doing the electrophoresis it shows up as the IgG spike even though the protein is not complete.